NCT00273052
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
See it on ClinicalTrials.gov ↗568 people
47.5%
52.5%
270 womenmiddle line = equal numbers298 men
- Phase
- PHASE3
- Paid for by
- GlaxoSmithKline
- Finished
- 2007-12-28
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- Not reported
- Age 65+
- 11.3%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 81.9% · Black / African American 9.2% · Other 9%
Women left out
- No diabetes
Women with diabetes were turned away.
“Has Type I or II diabetes.”
Study titles and rules are shown in their original English.